Insights On Partnering
-
Biopharma Giant Streamlines Infrastructure With Proprietary Software
11/17/2025
Archiving legacy QMS systems into a centralized platform reduced costs, simplified access, and improved efficiency for a global diagnostics company undergoing quality process harmonization.
-
Are You An Emerging Biotech? Things To Consider When Selecting A CRO
7/22/2024
Better understand how smaller biotech companies should approach CRO selection and what they should consider before launching their clinical development program.
-
The High Cost Of CRO Turnover (And How You Can Avoid It)
9/18/2024
Though some turnover is an inevitable part of a business’s life cycle, there are several strategies available to ensure a consistent CRO team throughout the span of your trial.
-
Metabolic Disorders Clinical Trial Case Study
9/17/2024
Check out this case study to learn how partnering with an accomplished contract research organization is essential in the complex and dynamic field of metabolic drug development.
-
Harnessing The Potential Of Patient-Level Data In Clinical Trials
6/19/2024
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
Addressing A Global Health Priority In Australia And New Zealand
11/7/2025
For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.
-
The Immune System's Secret Language: Unlocking Cellular Communication
10/15/2025
The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.
-
How Sponsors Can Leverage New Technologies To Lower Trial Costs
1/6/2025
This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.
-
Adaptive Clinical Trials
8/20/2024
An adaptive study design can be especially useful if there are uncertainties specific to your drug. Adjusting your study as data accumulates means getting answers sooner.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials
10/21/2025
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.